Commentary|Podcasts|January 20, 2025
Reaching Diverse Patient Populations With Personalized Treatment Methods
Author(s)Andy Studna, Senior Editor
Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses:
- Industry’s greatest challenges in reaching diverse patient populations
- Personalized treatment methods
- Recruitment strategies
- and more!
Related Content
Trending on Applied Clinical Trials Online
1
Quantifying the Net Financial Value of Deploying Risk-Based Quality Management
2
PLPS Launches MyClinicalSuite™ to Deliver Faster Clinical Trial Label Turnarounds Without Compromising Quality, Compliance, or Patient Safety
3
ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics
4
What Clinical Trials Can Learn from the Gig Economy About Payments
5